Weekly Analysts’ Ratings Updates for PACS Group (PACS)

Several brokerages have updated their recommendations and price targets on shares of PACS Group (NYSE: PACS) in the last few weeks:

• 3/4/2026 – PACS Group was upgraded by Zacks Research from “hold” to “strong-buy”.
• 3/4/2026 – PACS Group had its price target raised by UBS Group AG from $42.00 to $44.00. They now have a “buy” rating on the stock.
• 3/4/2026 – PACS Group had its price target raised by Oppenheimer Holdings, Inc. from $40.00 to $42.00. They now have an “outperform” rating on the stock.
• 2/27/2026 – PACS Group had its price target raised by Royal Bank Of Canada from $47.00 to $52.00. They now have an “outperform” rating on the stock.
• 2/15/2026 – PACS Group was upgraded by Wall Street Zen from “hold” to “buy”.
• 2/7/2026 – PACS Group was downgraded by Wall Street Zen from “buy” to “hold”.
• 1/30/2026 – PACS Group was upgraded by Zacks Research from “strong sell” to “hold”.

Insiders Place Their Bets

In related news, COO Joshua Jergensen sold 36,335 shares of the business’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $34.28, for a total value of $1,245,563.80. Following the completion of the transaction, the chief operating officer directly owned 2,667,347 shares in the company, valued at $91,436,655.16. The trade was a 1.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 70.40% of the company’s stock.

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.